Search

Your search keyword '"Boyington, Jeffrey C"' showing total 180 results

Search Constraints

Start Over You searched for: Author "Boyington, Jeffrey C" Remove constraint Author: "Boyington, Jeffrey C"
180 results on '"Boyington, Jeffrey C"'

Search Results

1. Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

2. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses

3. A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

4. Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

7. Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

8. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

9. Prefusion-Stabilized Lassa Virus Trimer Identifies Neutralizing Nanobodies and Reveals an Apex-Situated Site of Vulnerability

11. Protection of calves by a prefusion-stabilized bovine RSV F vaccine

14. Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses

16. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

17. Structural and genetic basis for development of broadly neutralizing influenza antibodies

18. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

19. Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base

20. Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains

22. Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains

23. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses

24. Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

25. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand

26. Protection of calves by a prefusion-stabilized bovine RSV F vaccine

28. Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin

29. Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

30. Structure of Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

31. Design of nanoparticulate group 2 influenza hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages

34. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies

35. Preferential induction of cross-group influenza A hemagglutinin stem–specific memory B cells after H7N9 immunization in humans

36. Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus

37. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

38. Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

39. Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04

Catalog

Books, media, physical & digital resources